Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cerevance, Inc.

News headline image
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Cerevance to Participate in Piper Sandler Virtual CNS Symposium
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Cerevance Announces Presentations at the Alzheimer's Association International Conference 2025
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Cerevance Presents Positive Results from Phase 1 Study of CVN293 at American Academy of Neurology 2025 Annual Meeting
From Cerevance, Inc.
Via GlobeNewswire
News headline image
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025
From Cerevance, Inc.
Via GlobeNewswire
News headline image
New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson’s Disease and Deep Pipeline for CNS-based Disorders
From Cerevance, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>